Bulletin
Investor Alert

Intra-Cellular Therapies Inc.

NAS: ITCI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 5, 2022, 7:09 p.m.

/zigman2/quotes/209441868/composite

$

60.20

Change

+0.21 +0.35%

Volume

Volume 12,473

Quotes are delayed by 20 min

/zigman2/quotes/209441868/composite

Previous close

$ 58.77

$ 59.99

Change

+1.22 +2.08%

Day low

Day high

$56.08

$61.00

Open

52 week low

52 week high

$28.40

$66.00

Open

Insider Actions for Intra-Cellular Therapies Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/30/2022 Rory Balfour Riggs
Director
289   Award at $57.08 per share. 16,496
06/30/2022 Robert L. van Nostrand
Director
108   Award at $57.08 per share. 6,164
05/12/2022 Joel S. Marcus
Director
10,000   Disposition at $55 per share. 550,000
04/08/2022 Mark Neumann
EVP, Chief Commercial Officer
14,885   Disposition at $65.14 per share. 969,608
04/08/2022 Mark Neumann
EVP, Chief Commercial Officer
53,987   Disposition at $64.42 per share. 3,477,842
04/08/2022 Mark Neumann
EVP, Chief Commercial Officer
17,476   Disposition at $63.55 per share. 1,110,599
04/08/2022 Mark Neumann
EVP, Chief Commercial Officer
86,348   Derivative/Non-derivative trans. at $12.73 per share. 1,099,210
03/31/2022 Rory Balfour Riggs
Director
257   Award at $61.19 per share. 15,725
03/31/2022 Robert L. van Nostrand
Director
126   Award at $61.19 per share. 7,709
03/18/2022 Rory Balfour Riggs
Director
15,736   Disposition at $61.35 per share. 965,403
03/18/2022 Rory Balfour Riggs
Director
4,901   Disposition at $60.63 per share. 297,147
03/17/2022 Rory Balfour Riggs
Director
114,912   Disposition at $60.41 per share. 6,941,833
03/17/2022 Rory Balfour Riggs
Director
26,587   Disposition at $59.99 per share. 1,594,954
03/16/2022 Rory Balfour Riggs
Director
43,848   Disposition at $59.53 per share. 2,610,271
03/16/2022 Rory Balfour Riggs
Director
20,686   Disposition at $58.72 per share. 1,214,681
03/09/2022 Sharon Mates
Chairman, President & CEO; Director
38,925   Derivative/Non-derivative trans. at $2.84 per share. 110,547
03/08/2022 Joel S. Marcus
Director
10,000   Disposition at $52.89 per share. 528,900
03/08/2022 Joel S. Marcus
Director
5,000   Disposition at $52.25 per share. 261,250
03/07/2022 Joel S. Marcus
Director
5,000   Disposition at $54.52 per share. 272,600

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
2 Purchases
1 Sales
397
10,000
Last 6 months
16 Purchases
39 Sales
248,736
465,701
Last 12 months
35 Purchases
73 Sales
741,824
996,227

Officers and Executives

Dr. Sharon Mates
Chairman, President & Chief Executive Officer
Mr. Lawrence J. Hineline
Chief Financial Officer, Treasurer & SVP-Finance
Dr. Willie R. Earley
Senior Vice President & Head-Clinical Development
Dr. Robert E. Davis
Chief Scientific Officer & Senior Vice President
Dr. Suresh Durgam
Chief Medical Officer & Executive Vice President
Ms. Karen Patruno Sheehy
Chief Compliance Officer & Senior Vice President
Mr. Mark Neumann
Chief Commercial Officer & Executive VP
Dr. Juan F. Sanchez
VP-Communications & Investor Relations
Mr. Michael Halstead
Secretary, Executive VP & General Counsel
Mr. Michael Olchaskey
Senior Vice President & Head-Regulatory Affairs
Mr. John A. Bardi
SVP-Market Access, Policy & Government Affairs
Dr. Michael Rawlins
Independent Director
Ms. Rene E. Salas
Independent Director
Mr. Joel S. Marcus
Independent Director
Mr. Rory B. Riggs
Independent Director
Mr. Robert L. van Nostrand
Lead Independent Director
Link to MarketWatch's Slice.